Bone Biologics Co. (NASDAQ:BBLGW – Get Free Report) shot up 10.8% on Friday . The company traded as high as $44.30 and last traded at $44.30. 809 shares were traded during mid-day trading, a decline of 66% from the average session volume of 2,400 shares. The stock had previously closed at $40.00.
Bone Biologics Price Performance
The company’s 50-day moving average is $29.88 and its 200-day moving average is $46.95.
About Bone Biologics
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.
Further Reading
- Five stocks we like better than Bone Biologics
- What is Short Interest? How to Use It
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- Investing in Construction Stocks
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for Bone Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bone Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
